Sectoral Asset Management Inc Mirati Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

$203 Million
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $7.37 Million - $10.9 Million	-175,430 Reduced 96.44%	6,474 $380,000
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $927,157 - $1.51 Million	33,351 Added 22.45%	181,904 $7.92 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $727,911 - $997,075	20,147 Added 15.69%	148,553 $5.37 Million
Q1 2023 May 12, 2023	BUY	$36.54 - $54.26 $2.25 Million - $3.34 Million	61,560 Added 92.09%	128,406 $4.77 Million
Q4 2022 Feb 10, 2023	BUY	$41.27 - $98.62 $302,509 - $722,884	7,330 Added 12.32%	66,846 $3.03 Million

Q3 2022 Nov 10, 2022	SELL	$59.5 - $86.7 $541,271 - $788,709	-9,097 Reduced 13.26%	59,516 $4.16 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $343,668 - $778,518	8,776 Added 14.67%	68,613 $4.61 Million
Q1 2022 May 10, 2022	SELL	$75.82 - $150.97 $1.21 Million - $2.42 Million	-16,000 Reduced 21.1%	59,837 $4.92 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $9.67 Million - $13.9 Million	73,286 Added 2872.83%	75,837 $11.1 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $15,855 - $21,294	120 Added 4.94%	2,551 $451,000
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $11 Million - $13.8 Million	-76,650 Reduced 96.93%	2,431 $393,000
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $865,001 - $1.21 Million	5,443 Added 7.39%	79,081 $13.5 Million
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $11.9 Million - $17.7 Million	73,638 New	73,638 $16.2 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $14.2 Million - $21 Million	-125,336 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $3.69 Million - $6.17 Million	51,236 Added 69.14%	125,336 $14.3 Million
Q1 2020 May 13, 2020	BUY	$69.78 - $116.21 $5.17 Million - $8.61 Million	74,100 New	74,100 $5.7 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.

Account